| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/03/2006 | CN1768069A Novel carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them |
| 05/03/2006 | CN1768065A Thienopyrimidine compound and use of the same |
| 05/03/2006 | CN1768059A Pyrido [2,3-d] pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents |
| 05/03/2006 | CN1768054A Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 05/03/2006 | CN1768040A Isoquinoline-5-sulfonic acid amides as inhibitors of AKT (protein kinase B) |
| 05/03/2006 | CN1767860A Methods and compositions for administering therapeutic and diagnostic agents |
| 05/03/2006 | CN1767848A Survivin-derived peptides and use thereof |
| 05/03/2006 | CN1767845A Composition for treating hepatitis c |
| 05/03/2006 | CN1767839A Antiallergic composition |
| 05/03/2006 | CN1767825A Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof |
| 05/03/2006 | CN1767078A Preparation of radium-223, physically accepted preparation and kit |
| 05/03/2006 | CN1765928A Reconstituted human anti-hm1.24 antibody |
| 05/03/2006 | CN1765393A Method for preparing anti-liver cancer component from selenium-enriched tea leaf and product thereof |
| 05/03/2006 | CN1765364A Lipid formulation of nolatrexed dihydrochloride and its preparation method |
| 05/03/2006 | CN1765356A Curcumenol solid lipid nano-particle and its preparation method |
| 05/03/2006 | CN1254541C Novel compound |
| 05/03/2006 | CN1254540C Cloning and expression of Baimei pit viper Aidingbit CDNA for treating tumor |
| 05/03/2006 | CN1254473C Process for crystallization of(R)-or(S)-lansoprazole |
| 05/03/2006 | CN1254272C Activation and inhibition of immune system |
| 05/03/2006 | CN1254253C Pain-eliminating anti-cancer traditional Chinese medicine and preparation process thereof |
| 05/03/2006 | CN1254245C Hydroxy camptothecin emulsion and its preparation method |
| 05/03/2006 | CN1254234C Plasmid DNA (Lipogenes TM) and encapsulating therapeutica agent containing karyon-positioning signal /fusion-promoting peptide conjugate into targeted liposomes complex |
| 05/03/2006 | CN1254199C Multi-purpose high-function alkaline solution composition, its preparing process and its usage as non-specific immanopotentiator |
| 05/02/2006 | US7038051 Imidazonaphthyridines |
| 05/02/2006 | US7038049 Anticancer agents; antitumor agents; apoptosis of breast tumor cells; drug resistance leukemia |
| 05/02/2006 | US7038048 Compositions for treatment of cell proliferation disorders |
| 05/02/2006 | US7038035 Nucleic acids codes polypeptides; mutants; insertion a vector; culturing; recovering |
| 05/02/2006 | US7038029 Vaccination |
| 05/02/2006 | US7038028 Gene encoding promoter domain of tumor suppressor gene P51 and use thereof |
| 05/02/2006 | US7038013 Nucleotide sequences coding polypeptide for use in treatment of immune respone defects |
| 05/02/2006 | US7037940 Taxol enhancer compounds |
| 05/02/2006 | US7037929 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/02/2006 | US7037928 Compositions of N-(methylethylaminocarbonyl)-4-(-3-methylphenylamino)-3-pyridylsulfonamide and cyclic oligosaccharides |
| 05/02/2006 | US7037926 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases |
| 05/02/2006 | US7037925 for treating or preventing organ transplant rejection, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes, asthma, rhinitis, atopic dermatitis, autoimmune disorders, Alzheimer's disease, leukemia |
| 05/02/2006 | US7037921 Compounds and methods for inhibiting MRP1 |
| 05/02/2006 | US7037920 Substituted tricyclic himbacine derivatives that are useful as thrombin receptor antagonists |
| 05/02/2006 | US7037919 novel nonsteroidal compounds and salts; have a specific and strong binding affinity for androgen receptors and exhibit AR agonism or antagonism; therapeutic effect on AR-mediated diseases such as male hypogonadism, male sexual dysfunction, anemia, aids, breast, prostate cancer |
| 05/02/2006 | US7037918 Antidiabetic agents, cardiovascular disorders, Alzheimer's disease, nervous system disorders |
| 05/02/2006 | US7037916 Antiinflammatory agents; antiarthritic agents; anticholesterol agents; cardiovascular disorders; muscle and skin disorders |
| 05/02/2006 | US7037909 Tetracyclic compounds as c-Met inhibitors |
| 05/02/2006 | US7037907 Prodrug of an estradiol conjugated to a glucuronide sugar; 6-oxo-2-methoxyestradiol; 3-acetyl-6-oxo-2-methoxyestradiol; and 2-methoxyestradiol-6-hydrazone; angiogenesis inhibitor; antiinflammatory for asthma or rheumatoid arthritis |
| 05/02/2006 | US7037904 Improved appetite and energy level; reduced nausea and vomiting; immunostimulation; sleep and emotional support |
| 05/02/2006 | US7037898 Tumor-activated prodrug compounds and treatment |
| 05/02/2006 | US7037896 HIV inhibiting peptide (VIRIP) and amidated, acetylated, sulfated, polyethylene glycol modified, phosphorylated and/or glycosylated derivatives |
| 05/02/2006 | US7037718 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 05/02/2006 | US7037702 Hydrolase polypeptide for dephosphorylating mitogen activated kinases (MAP-kinase); antiapoptosis; antiproliferative agents |
| 05/02/2006 | US7037701 Genetic engineering; detection moderators of kinase peptidespeptides |
| 05/02/2006 | US7037685 Nucleotide sequence coding polypeptide for use in the treatment and prevent of viral diseases, infections and tumors |
| 05/02/2006 | US7037668 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616 |
| 05/02/2006 | US7037666 Contacting latency-associated peptide- beta 1 (LAP- beta 1) or a functional variant thereof and integrin alpha v beta 3 or a functional variant thereof with test product under conditions that, in absence of test product, would permit interaction |
| 05/02/2006 | US7037665 Compositions comprising SNORF36 receptor compounds |
| 05/02/2006 | US7037652 Diagnosing prostate cancer in humans; obtain tissue sample, monitor gene expression, compare to control, evaluate for cancer |
| 05/02/2006 | US7037647 Prostate-specific membrane antigen and uses thereof |
| 05/02/2006 | US7037533 Functional agent for decomposing nicotine and method of preparing the same |
| 05/02/2006 | US7037498 Antibodies to insulin-like growth factor I receptor |
| 05/02/2006 | CA2401191C A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer |
| 05/02/2006 | CA2358394C Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 05/02/2006 | CA2334012C 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 05/02/2006 | CA2184375C Oligonucleotide n3'-p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties |
| 05/02/2006 | CA2149529C Peptides and anti-sense peptides with broad neoplastic specificity |
| 05/02/2006 | CA2149147C Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof |
| 04/27/2006 | WO2006045049A1 Angiopoietin-2 specific binding agents |
| 04/27/2006 | WO2006044984A1 Inhibition of tumor growth and metastasis by atf2-derived peptides |
| 04/27/2006 | WO2006044933A2 Compositions and methods for disruption of brca2-rad51 interaction |
| 04/27/2006 | WO2006044869A1 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase |
| 04/27/2006 | WO2006044823A2 Heteroaryl-substituted alkyne compounds and method of use |
| 04/27/2006 | WO2006044707A1 Chemical compounds |
| 04/27/2006 | WO2006044687A2 Kinase inhibitors |
| 04/27/2006 | WO2006044682A1 Compounds for nonsense suppression, and methods for their use |
| 04/27/2006 | WO2006044524A1 Benzothieno’2,3-d! pyrimidine compounds as inhibitors of tyrosine kinase activities of the epidermal growth factor receptors (egfrs) for the treatment of hyperproliferative diseases |
| 04/27/2006 | WO2006044457A1 N-benzenesulfonyl substituted anilino-pyrimidine analogs |
| 04/27/2006 | WO2006044453A1 Analogs of 17-hydroxywortmannin as pi3k inhibitors |
| 04/27/2006 | WO2006044451A1 Treatment of osteoarthritis and dosing regimen for arzoxifene |
| 04/27/2006 | WO2006044402A1 Furazano `3, 4-b ! pyrazynes and their use as anti-tumor agents |
| 04/27/2006 | WO2006044379A2 Novel curcumin analogues and uses thereof |
| 04/27/2006 | WO2006044176A1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 04/27/2006 | WO2006043891A1 Immunoregulation in cancer, chronic inflammatory and autoimmune diseases |
| 04/27/2006 | WO2006043839A1 Nitrobenzindoles and their use in cancer therapy |
| 04/27/2006 | WO2006043783A1 Pharmaceutical compositions, comprising red ginseng acid polysaccharide and lentinus edodes, of preventing and treating cancer |
| 04/27/2006 | WO2006043722A1 Chimeric (double) decoy |
| 04/27/2006 | WO2006043671A1 TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO |
| 04/27/2006 | WO2006043615A1 Use of immunesuppressant receptor |
| 04/27/2006 | WO2006043090A1 Imidazo[4,5-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-one compounds and analogs thereof as therapeutic compounds |
| 04/27/2006 | WO2006043031A2 Class iii slrp for the treatment of cancer |
| 04/27/2006 | WO2006042599A1 Phenylurea derivatives used as inhibitors of tyrosinkinase for treating tumors |
| 04/27/2006 | WO2006042479A1 Pharmaceutical composition and non dependence coffee comprising edible carboxylic acid and/or its acid salt and coffeine |
| 04/27/2006 | WO2006042465A1 A vaccine composition containing a recombinant fusion protein and a adjuvant as well as its application |
| 04/27/2006 | WO2006042418A1 Antiviral oligonucleotides |
| 04/27/2006 | WO2006042414A1 Improved viral purification methods |
| 04/27/2006 | WO2006042362A1 Use of 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide to inhibit the tyrosine kinase receptor c-fms |
| 04/27/2006 | WO2006029146A3 6H-[1]BENZOPYRANO[4,3-b]QUINOLINES AND THEIR USE AS ESTROGENIC AGENTS |
| 04/27/2006 | WO2006021660A8 Use of at least one conjugated triene-containing fatty acid for preparing a medicine for treating inflammation |
| 04/27/2006 | WO2006021379A8 Dihydropteridinone derivatives, methods for the production thereof and their use as medicaments |
| 04/27/2006 | WO2006021378A8 Dihydropteridinone derivatives, methods for the production thereof and their use as medicaments |
| 04/27/2006 | WO2006015382A3 Integrin alpha-v beta-3 antagonists for use in imaging and therapy |
| 04/27/2006 | WO2006009919A3 Improved efficacy of immunotherapy by integrating diagnostic with therapeutic methods |
| 04/27/2006 | WO2006005581A3 A composition comprising a pharmacologically active agent coupled to a target cell specific component, and a saponin |
| 04/27/2006 | WO2005117848A9 Vascular targets for detecting, imaging and treating neoplasia or neovasculature |
| 04/27/2006 | WO2005105143A3 Vaccines and antibodies against ltk for therapy of cancers. |